首页> 外文期刊>Scientific reports. >Quantitative study of 18 F-(+)DTBZ image: comparison of PET template-based and MRI based image analysis
【24h】

Quantitative study of 18 F-(+)DTBZ image: comparison of PET template-based and MRI based image analysis

机译:18 F - (+)DTBZ图像的定量研究:基于PET模板和MRI基于MRI的图像分析的比较

获取原文
           

摘要

[18F]9-fluoropropyl-(+)-dihydrotetrabenazine (18F-(+)DTBZ) is a recently developed PET tracer to investigate the vesicular monoamine transporter type 2 (VMAT2) activity in measuring dopaminergic degeneration in vivo and monitoring the severity of Parkinson’s disease (PD). However, manual drawing of the striatal regions is time consuming and prone to human bias. In the current study, we developed an automated method to quantify the signals of the striatum on 18F-(+)DTBZ images. 39 patients with PD and 26 controls were enrolled. Traditional brain magnetic resonance imaging (MRI) and 18F-(+)DTBZ PET were acquired. Both indirect normalization of native PET images to the standard space through individual brain MRI and directly coregistration of native images to the transporter-specific PET template in standard space were performed. Specific uptake ratios (SURs) in 10 predefined regions were used as indicators of VMAT2 activities to correlate with motor severity. Our results showed patients with PD had significant lower SURs in the bilateral putamina, caudates and globus pallidi than controls. SURs in the caudate and putamen were significantly correlated with motor severity. The contralateral putaminal region performed best in discriminating between PD patients and controls. Finally, the results from the application of the 18F-(+)DTBZ PET template were comparable to those derived from the traditional MRI based method. Thus, 18F-(+)DTBZ PET imaging holds the potential to effectively differentiate PD patients from controls. The 18F-(+)DTBZ PET template-based method for automated quantification of presynaptic VMAT2 transporter density is easier to implement and may facilitate efficient, robust and user-independent image analysis.
机译:[18F] 9-氟丙基 - (+) - 二氢丙基苯嗪(18F - (+)DTBZ)是最近开发的PET示踪剂,以研究测量体内多巴胺能变性的凹凸单胺转运蛋白2(VMAT2)活性,并监测帕金森的严重程度疾病(PD)。然而,手动绘制纹纹版区域是耗时和易于人类偏见。在目前的研究中,我们开发了一种自动化方法,用于量化18F - (+)DTBZ图像上的纹章的信号。 39例PD和26例对照的患者进行了注册。获得了传统的脑磁共振成像(MRI)和18F - (+)DTBZ PET。进行通过单个脑MRI对标准空间的天然PET图像的间接标准化,并在标准空间中直接对运输机构的宠物模板直接进行天然图像。 10个预定区域中的特定摄取比(Surs)用作VMAT2活性的vmat2活性的指标。我们的结果表明,PD患者在双侧普垫片中具有显着的较低水分,尾巴和Globus Pallidi比对照组。尾部和腐烂中的Surs与电机严重程度显着相关。对侧底骨区域在PD患者和对照之间的鉴别方面表现最佳。最后,来自18F - (+)DTBZ PET模板的应用的结果与来自传统的MRI基法衍生的结果相当。因此,18F - (+)DTBZ PET成像具有有效地区分PD患者免受对照的潜力。基于18F - (+)DTBZ PET模板的预先定量的基于突触前VMAT2运输密度的方法更容易实现,并且可以促进高效,鲁棒和独立于用户的图像分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号